Orchid, Aurobindo get nod to sell Schizophrenia drug copy
Orchid Chemicals and Pharmaceuticals and rival Aurobindo Pharma have received US Food and Drug Administration (FDA) approval for their abbreviated new drug application (ANDA) for Olanzapine tablets, a generic version of Eli Lilly's Zyprexa tablets, in various strengths.
April 25, 2012 / 15:47 IST
Moneycontrol Bureau
Orchid Chemicals and Pharmaceuticals and rival Aurobindo Pharma have received US Food and Drug Administration (FDA) approval for their abbreviated new drug application (ANDA) for Olanzapine tablets, a generic version of Eli Lilly's Zyprexa tablets, in various strengths.Olanzapine tablets are indicated for the treatment of schizophrenia, and bipolar disorder and had annual sales of USD 3.3 billion for year ended Dec 31, the companies said citing IMS Health data.Sun Pharmaceutical Industries, Dr Reddy's Laboratories, and US-based Mylan have also entered the growing pool of Zyprexa generics, having received US FDA approvals in the last couple of days.Aurobindo Pharma said its copy of Zyprexa has been approved out of Unit VII formulations facility in Hyderabad.Orchid Chemicals shares closed down 0.5% at Rs 181.80 on NSE. Aurobindo was down 1.6% at Rs 127.30. Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
